Nobilis® Rismavac+CA126
Nobilis Rismavac +CA126 consists of a suspension of living cultured avian cells containing attenuated Marek's Disease virus and Turkey Herpes Virus.
Presentation
Nobilis Rismavac+CA126 is supplied in frozen ampoules held in metal canes stored in a liquid nitrogen canister. Solvent is supplied for reconstitution of the vaccine prior to use.
Active ingredients
Nobilis Rismavac+CA126 consists of a suspension of living, cultured avian cells containing at least 3.0 log10 PFU Marek's Disease virus (strain CVI 998) and at least 3.0 log10 PFU Turkey Herpes Virus (strain FC 126) per dose. The vaccine contains stabilisers and traces of antibiotics (neomycin and polymyxin or gentamycin, and amphotericin B).
Target species
Chickens
Indications for use
Nobilis Rismavac+CA126 is for active immunisation of chickens to reduce mortality, clinical signs and lesions after infection with Marek’s disease virus (MDV).
Withdrawal periods
Zero days
Packaging
Ampoules containing 1,000 or 2,000 doses supplied together with Nobilis Solvent CA
Legal category
POM-VPS
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation:November 2025
